VolitionRx Future Growth
Future criteria checks 2/6
VolitionRx is forecast to grow earnings and revenue by 47.5% and 54.8% per annum respectively while EPS is expected to grow by 50.5% per annum.
Key information
47.5%
Earnings growth rate
50.5%
EPS growth rate
Medical Equipment earnings growth | 16.0% |
Revenue growth rate | 54.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Apr 2024 |
Recent future growth updates
Recent updates
Do Institutions Own VolitionRx Limited (NYSEMKT:VNRX) Shares?
Mar 17This Insider Has Just Sold Shares In VolitionRx Limited (NYSEMKT:VNRX)
Feb 10Market Sentiment Around Loss-Making VolitionRx Limited (NYSEMKT:VNRX)
Jan 27Have Insiders Been Selling VolitionRx Limited (NYSEMKT:VNRX) Shares This Year?
Dec 29What Type Of Shareholders Own The Most Number of VolitionRx Limited (NYSEMKT:VNRX) Shares?
Nov 30Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 61 | -5 | -1 | 0 | 3 |
12/31/2025 | 16 | -32 | -26 | -25 | 4 |
12/31/2024 | 4 | -36 | -31 | -29 | 4 |
12/31/2023 | 1 | -35 | -19 | -18 | N/A |
9/30/2023 | 1 | -34 | -32 | -30 | N/A |
6/30/2023 | 1 | -33 | -30 | -29 | N/A |
3/31/2023 | 0 | -31 | -29 | -28 | N/A |
12/31/2022 | 0 | -30 | -17 | -15 | N/A |
9/30/2022 | 0 | -31 | -15 | -14 | N/A |
6/30/2022 | 0 | -30 | -13 | -12 | N/A |
3/31/2022 | 0 | -28 | -12 | -11 | N/A |
12/31/2021 | 0 | -27 | -22 | -21 | N/A |
9/30/2021 | 0 | -24 | -21 | -19 | N/A |
6/30/2021 | 0 | -21 | -21 | -19 | N/A |
3/31/2021 | 0 | -21 | -20 | -18 | N/A |
12/31/2020 | 0 | -20 | -18 | -16 | N/A |
9/30/2020 | 0 | -19 | -17 | -16 | N/A |
6/30/2020 | 0 | -19 | -16 | -16 | N/A |
3/31/2020 | 0 | -18 | -15 | -14 | N/A |
12/31/2019 | 0 | -16 | -13 | -13 | N/A |
9/30/2019 | 0 | -17 | -14 | -14 | N/A |
6/30/2019 | N/A | -17 | -15 | -15 | N/A |
3/31/2019 | N/A | -18 | -15 | -15 | N/A |
12/31/2018 | N/A | -18 | -15 | -15 | N/A |
9/30/2018 | N/A | -18 | -15 | -15 | N/A |
6/30/2018 | N/A | -17 | -14 | -13 | N/A |
3/31/2018 | N/A | -16 | -14 | -13 | N/A |
12/31/2017 | N/A | -15 | -14 | -12 | N/A |
9/30/2017 | N/A | -14 | N/A | -10 | N/A |
6/30/2017 | N/A | -13 | N/A | -10 | N/A |
3/31/2017 | N/A | -13 | N/A | -9 | N/A |
12/31/2016 | N/A | -12 | N/A | -9 | N/A |
9/30/2016 | N/A | -12 | N/A | -9 | N/A |
6/30/2016 | N/A | -11 | N/A | -9 | N/A |
3/31/2016 | N/A | -10 | N/A | -9 | N/A |
12/31/2015 | N/A | -10 | N/A | -9 | N/A |
9/30/2015 | 0 | -8 | N/A | -7 | N/A |
6/30/2015 | N/A | -11 | N/A | -6 | N/A |
3/31/2015 | N/A | -8 | N/A | -5 | N/A |
12/31/2014 | N/A | -8 | N/A | -4 | N/A |
9/30/2014 | 0 | -8 | N/A | -4 | N/A |
6/30/2014 | N/A | -3 | N/A | -4 | N/A |
3/31/2014 | N/A | -5 | N/A | -4 | N/A |
12/31/2013 | N/A | -4 | N/A | -3 | N/A |
9/30/2013 | N/A | -4 | N/A | -3 | N/A |
6/30/2013 | 0 | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VNRX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VNRX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VNRX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VNRX's revenue (54.8% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: VNRX's revenue (54.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VNRX's Return on Equity is forecast to be high in 3 years time